End Stage Renal Disease. End Stage Renal Disease
Conditions
Interventions
Intervention 1: Cap Omega-3 1000mg, 3 capsules per day for 2 months manufactured by Zahravi company. Intervention 2: Cap placebo, 3 capsules per day for 2 months manufactured by Zahravi company.
Treatment - Drugs
Placebo
Cap Omega-3 1000mg, 3 capsules per day for 2 months manufactured by Zahravi company
Cap placebo, 3 capsules per day for 2 months manufactured by Zahravi company
Sponsors
Vice Chancell for Research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
16 Years to 99 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: consent for cooperation; hemodialysis for at least 3 months; pruritus duration > 8 weeks; without any dermatologic problems; no hypersensitivity to omega-3; no malabsorption or other gastrointestinal problems (chronic diarrhea >2 weeks); not using anticoagulant and antiplatelet drugs. Exclusion criteria: incompliance; kidney transplantation; antihistamin or Gabapentin using; anemia (Hb 300microg/L ; Phosphorus >7mg/dL ; INR rising
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pruritus score. Timepoint: At the begining, every 2 weeks and end of study. Method of measurement: Questionaire (visual analog scale).;Serum Prostaglandin E2. Timepoint: At the begining and end of study. Method of measurement: ELISA Kit,. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Masoud Moghtaderi
Isfahan University of Medical Sciences
Outcome results
None listed